Chris Giblin
🏛️ Revolving DoorFormer Government Positions:
COS, Cong. Carter; LD, Norwood; LA, Fields
COS, Rep. Carter; LD, Rep. Norwood; LA, Rep. Fields
Chief of Staff, Rep. John Carter; Legislative Director, Rep. Charlie Norwood
🤖
AI Overview
Chris Giblin has appeared in 1,945 federal lobbying filings at Ogr, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 50 policy areas.
1,945
Total Filings
1
Firms
50
Clients
50
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 193 | 31 |
| 2019 | 188 | 29 |
| 2020 | 205 | 29 |
| 2021 | 226 | 35 |
| 2022 | 274 | 36 |
| 2023 | 300 | 43 |
| 2024 | 289 | 36 |
| 2025 | 270 | 36 |
Firms
Ogr1945 filings
Top Clients
Global Business Alliance171 filings
H-e-b116 filings
The Sherwin-williams Company112 filings
Ecolab INC. on Behalf of Nalco Company105 filings
Bath & Body Works, INC.71 filings
Rheem Manufacturing Company67 filings
PMI US Corporate Services INC.67 filings
Constellation Energy Generation, LLC66 filings
Pfizer INC59 filings
Nike, INC.59 filings
American Petroleum Institute52 filings
Carvana41 filings
Directv, LLC38 filings
Innovative Payments Association36 filings
Core Natural Resources, INC.35 filings
American Chemistry Council35 filings
AT&T Services, INC.32 filings
Accus32 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Foreign Governments Are Lobbying Congress
1,000+ foreign entities from 50+ countries lobby the US government.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.